Summary & Overview
CPT 80329: Detection or Measurement of One or Two Nonopioid Analgesics
CPT code 80329 covers laboratory analysis to detect or measure one or two nonopioid analgesic medications in a patient specimen. Nationally, this code supports clinical care by confirming medication exposure, guiding pain-management decisions, and informing safety monitoring. It applies across outpatient and inpatient laboratory settings where toxicology or therapeutic drug monitoring is performed. Key payers discussed in this overview include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the service and its clinical context, payer coverage considerations, and benchmarks for utilization and reimbursement practices. The publication outlines how 80329 is used in clinical workflows, common sites of service, and how payers categorize and price laboratory analytic services for nonopioid analgesics. It also highlights typical billing scenarios and where to look for policy updates related to laboratory drug testing. Data not available in the input is noted where applicable, and the content focuses on national implications rather than regional specifics.
Billing Code Overview
CPT code 80329 describes a laboratory test in which a lab analyst measures the amount of or detects the presence of one or two nonopioid analgesics (pain medications) in a patient specimen. This service captures qualitative or quantitative detection of specified nonopioid pain-relief agents.
-
Service type: Laboratory testing for therapeutic drug detection and measurement
-
Typical site of service: Clinical laboratory, hospital laboratory, or outpatient specimen collection site
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting for toxicology testing to confirm the presence or quantify one or two nonopioid analgesic medications (for example, acetaminophen, nonsteroidal anti-inflammatory drugs) after an acute overdose, preoperative assessment, or therapeutic drug monitoring. The clinical workflow begins when the ordering clinician (emergency physician, primary care physician, surgeon, or outpatient clinic provider) requests a targeted nonopioid analgesic assay. A specimen (typically blood serum or plasma, occasionally urine) is collected and labeled, transported to the clinical laboratory, and received by the medical technologist. The lab analyst performs the assay using immunoassay, enzymatic, or chromatographic methods to detect or measure one or two nonopioid analgesic agents. Results are reviewed by the laboratory director or supervising pathologist if required, reported in the electronic medical record, and communicated to the ordering provider for clinical decision-making such as antidote administration, medication adjustment, or discharge instructions. Typical sites of service include hospital emergency departments, inpatient hospital laboratories, outpatient hospital-based laboratories, and independent clinical laboratories or reference laboratories performing toxicology testing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation or supervision of the laboratory test separate from the technical component. |